Paul L. Jenkinson, Chief Financial Officer at Kite Pharma, Inc. (KITE), bought 3,450 shares at $72.59 ($250K) on 2017-05-10, disclosed to the SEC on 2017-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.57 | 450 | $33K | 13.0% |
| 2 | $72.59 | 3,000 | $218K | 87.0% |
| Total | $72.59 avg | 3,450 | $250K | 100% |